Armata Pharmaceuticals, Inc. (ARMP)

Armata Pharmaceuticals Statistics

Total Valuation

ARMP has a market cap or net worth of $342.52 million. The enterprise value is $621.85 million.

Market Cap	342.52M
Enterprise Value	621.85M

Important Dates

The last earnings date was Wednesday, March 25, 2026, after market close.

Earnings Date	Mar 25, 2026
Ex-Dividend Date	n/a

Share Statistics

ARMP has 36.63 million shares outstanding. The number of shares has decreased by -38.64% in one year.

Current Share Class	36.41M
Shares Outstanding	36.63M
Shares Change (YoY)	-38.64%
Shares Change (QoQ)	+0.35%
Owned by Insiders (%)	0.78%
Owned by Institutions (%)	3.43%
Float	11.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	69.84
Forward PS	453.78
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	126.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.19

Current Ratio	1.19
Quick Ratio	1.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.88

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-23.90%
Return on Invested Capital (ROIC)	-26.38%
Return on Capital Employed (ROCE)	-45.96%
Weighted Average Cost of Capital (WACC)	8.53%
Revenue Per Employee	$81,733
Profits Per Employee	-$2.90M
Employee Count	60
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +456.55% in the last 52 weeks. The beta is 1.39, so ARMP's price volatility has been higher than the market average.

Beta (5Y)	1.39
52-Week Price Change	+456.55%
50-Day Moving Average	8.66
200-Day Moving Average	5.15
Relative Strength Index (RSI)	50.19
Average Volume (20 Days)	32,812

Short Selling Information

The latest short interest is 310,810, so 0.85% of the outstanding shares have been sold short.

Short Interest	310,810
Short Previous Month	298,337
Short % of Shares Out	0.85%
Short % of Float	2.81%
Short Ratio (days to cover)	6.69

Income Statement

In the last 12 months, ARMP had revenue of $4.90 million and -$173.80 million in losses. Loss per share was -$4.80.

Revenue	4.90M
Gross Profit	4.90M
Operating Income	-31.22M
Pretax Income	-173.80M
Net Income	-173.80M
EBITDA	-29.69M
EBIT	-31.22M
Loss Per Share	-$4.80

Balance Sheet

The company has $8.69 million in cash and $288.02 million in debt, with a net cash position of -$279.33 million or -$7.63 per share.

Cash & Cash Equivalents	8.69M
Total Debt	288.02M
Net Cash	-279.33M
Net Cash Per Share	-$7.63
Equity (Book Value)	-218.60M
Book Value Per Share	-6.00
Working Capital	1.72M

Cash Flow

In the last 12 months, operating cash flow was -$25.76 million and capital expenditures -$542,000, giving a free cash flow of -$26.31 million.

Operating Cash Flow	-25.76M
Capital Expenditures	-542,000
Depreciation & Amortization	1.53M
Net Borrowing	25.00M
Free Cash Flow	-26.31M
FCF Per Share	-$0.72

Margins

Gross Margin	100.00%
Operating Margin	-636.66%
Pretax Margin	-3,544.03%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ARMP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	38.64%
Shareholder Yield	38.64%
Earnings Yield	-50.74%
FCF Yield	-7.68%

Analyst Forecast

The average price target for ARMP is $15.00, which is 60.43% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	60.43%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	71.52%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1